Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CENTURIA CAPITAL GROUP Capital/Financing Update 2019

Oct 22, 2019

64677_rns_2019-10-22_8dae64de-2534-4a73-a704-32a9613c7354.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Centuria Capital Group ( CNI ), consisting of Centuria Capital Limited ABN 22 095 454 336 ( Company ) and Centuria Funds Management Limited ACN 607 153 588) ( Responsible Entity ) as responsible entity of the Centuria Capital Fund (ARSN 613 856 358 ( Trust )

ABN

Company - ABN 22 095 454 336 Responsible Entity – ACN 607 153 588 Trust - ARSN 613 856 358

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of +securities issued Performance rights issued under the Centuria or to be issued Capital Group Executive Incentive Plan ( Performance Rights ). 2 Number of[+] securities 1,332,819 Performance Rights issued or to be issued (if known) or maximum number which may be issued

  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

3 Principal terms of the The 1,332,819 Tranche 7 Performance Rights were +securities (e.g. if options, issued to non-director executives. exercise price and expiry date; if partly paid +securities, the amount The principal terms of the Performance Rights are summarised in Item 5 of the Explanatory outstanding and due dates Notes contained within the Notice of Meeting for payment; if +convertible securities, the dated 14 October 2019 despatched to convene the conversion price and dates 2019 Annual General Meeting of CNI for conversion) securityholders. 4 Do the[+] securities rank Stapled Securities allocated upon vesting of the equally in all respects from Performance Rights will rank equally with the the[+] issue date with an existing Stapled Securities on issue. existing[+] class of quoted +securities? If the additional +securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or Nil. consideration 6 Purpose of the issue Issue of Performance Rights to non-director (If issued as consideration executives pursuant to CNI's Executive Incentive for the acquisition of Plan. assets, clearly identify those assets)

Appendix 3B Page 2

04/03/2013

6a
Is the entity an+eligible
entity that has obtained
security holder approval
under rule 7.1A?
If Yes, complete sections
6b – 6h_in relation to the_
+securities the subject of
this Appendix 3B, and
comply with section 6i
6b
The date the security
holder resolution under
rule 7.1A was passed
6c
Number of+securities
issued without security
holder approval under rule
7.1
6d
Number of+securities
issued with security holder
approval under rule 7.1A
6e
Number of+securities
issued with security holder
approval under rule 7.3, or
another specific security
holder approval (specify
date of meeting)
6f
Number of+securities
issued under an exception
in rule 7.2
6g
If+securities issued under
rule 7.1A, was issue price at
least 75% of 15 day VWAP
as calculated under rule
7.1A.3? Include the+issue
date and both values.
Include the source of the
VWAP calculation.
6h
If+securities were issued
under rule 7.1A for non-
cash consideration, state
date on which valuation of
consideration was released
to ASX Market
Announcements
No
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

6i
Calculate the entity’s
remaining issue capacity
under rule 7.1 and rule 7.1A
– complete Annexure 1 and
release to ASX Market
Announcements
7
+Issue dates
Note:
The
issue
date
may
be
prescribed by ASX (refer to the
definition of issue date in rule 19.12).
For example, the issue date for a pro
rata entitlement issue must comply
with the applicable timetable in
Appendix 7A.
Cross reference: item 33 of Appendix
3B.
8
Number and+class of all
+securities quoted on ASX
(_including_the+securities
in section 2 if applicable)
9
Number and+class of all
+securities not quoted on
ASX (_including_the
+securities in section 2 if
applicable)
10
Dividend policy (in the
case of a trust, distribution
policy) on the increased
capital (interests)
Not applicable
21 October 2019
Number +Class
438,789,792 Fully paid Stapled
Securities
Number +Class
1,921,149 Tranche 5
Performance Rights
2,336,399 Tranche 6
Performance Rights
1,332,819 Tranche 7
Performance Rights
20,098,470 options over
unissued Stapled
Securities
Performance Rights
issued pursuant to
CNI's Executive
Incentive Plan.
Options
The Performance Rights do not carry a right to a
dividend or distribution prior to vesting.

Part 2 - Pro rata issue

11
Is security holder approval
required?
Not applicable

Appendix 3B Page 4

04/03/2013

12
Is the issue renounceable
or non-renounceable?
13
Ratio in which the
+securities will be offered
14
+Class of+securities to
which the offer relates
15
+Record date to determine
entitlements
16
Will holdings on different
registers (or subregisters)
be aggregated for
calculating entitlements?
17
Policy for deciding
entitlements in relation to
fractions
18
Names of countries in
which the entity has
security holders who will
not be sent new offer
documents
Note: Security holders must be told
how their entitlements are to be dealt
with.
Cross reference: rule 7.7.
19
Closing date for receipt of
acceptances or
renunciations
20
Names of any
underwriters
21
Amount of any
underwriting fee or
commission
22
Names of any brokers to
the issue
23
Fee or commission
payable to the broker to
the issue
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

24
Amount of any handling
fee payable to brokers who
lodge acceptances or
renunciations on behalf of
security holders
25
If the issue is contingent
on security holders’
approval, the date of the
meeting
26
Date entitlement and
acceptance form and offer
documents will be sent to
persons entitled
27
If the entity has issued
options, and the terms
entitle option holders to
participate on exercise, the
date on which notices will
be sent to option holders
28
Date rights trading will
begin (if applicable)
29
Date rights trading will
end (if applicable)
30
How do security holders
sell their entitlements_in_
_full_through a broker?
31
How do security holders
sell_part_of their
entitlements through a
broker and accept for the
balance?
32
How do security holders
dispose of their
entitlements (except by
sale through a broker)?
33
+Issue date
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable

Appendix 3B Page 6

04/03/2013

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

  • 1 - 1,000

  • 1,001 - 5,000

  • 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

  • 38 Number of[+] securities for which Not applicable +quotation is sought

  • 39 +Class of +securities for which Not applicable quotation is sought

  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

  • 40 Do the[+] securities rank equally in Not applicable all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state:

  • the date from which they do

  • • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security)

Not applicable

Number +Class 42 Number and[+] class of all Not applicable Not applicable +securities quoted on ASX ( including the[+] securities in clause 38)

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of

Appendix 3B Page 8

04/03/2013

the Corporations Act (on the basis that the Performance Rights are not transferrable) .

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: Date: 23 October 2019 Company secretary

Print name: Anna Kovarik

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013